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Research
Parkinson’s disease (PD) is a chronic, progres-
sive, neurodegenerative movement disorder 
characterized by a loss of the neurotransmitter 
dopamine. The dopamine transporter (DAT) 
is responsible for the reuptake of dopamine 
into presynaptic neurons, which terminates 
dopamine neurotransmission and thus plays a 
central role in the spatial and temporal buff-
ering of released dopamine and its recycling 
(Uhl 2003). In drug-naive patients with PD, 
the levels of DAT protein are dramatically 
reduced (Lee et al. 2000). Human genetic 
variability in DAT, the gene encoding DAT 
(SLC6A3, GeneID 6531; National Center for 
Biotechnology Information 2009) has been 
associated with disorders and behaviors thought 
to be influenced by dopamine signaling such as 
attention-deficit hyperactivity disorder (Yang 
et al. 2007), bipolar disorders (Greenwood 
et al. 2006), and smoking cessation (Stapleton 
et al. 2007). DAT gene deletion in the mouse 
results in hyperactivity (Gainetdinov 1997; 
Giros et al. 1996), and when tyrosine hydroxy-
lase is also inhibited, these animals show physi-
cal behaviors (e.g., akinesia, rigidity, tremor) 
that phenotypically resemble the motor symp-
toms of PD (Sotnikova et al. 2006).
Given its central role in dopaminergic 
neurotransmission, DAT has been studied as a 
candidate gene for PD but with largely equiv-
ocal results (Bagade et al. 2008). However, PD 
is considered to have a multifactorial etiology, 
and further insight into the role of DAT gene 
variants on PD risk might be obtained from 
investigations of gene–environment interac-
tions. Kelada et al. (2006) first reported on 
the combined effect of DAT genetic variability 
and occupational pesticide exposure. Their 
gene–environment interaction investigation 
was prompted by the hypothesis that DAT 
can selectively carry certain neurotoxicants 
into dopaminergic neurons; for example, 
1-methyl-4-phenylpyridinium ion (MPP+), 
a complex I mitochondrial poison, has dev-
astating effects on the basal ganglia due to 
its selective uptake into dopaminergic neu-
ronal terminals via DAT (Gainetdinov 1997; 
Javitch et al. 1985; Langston et al. 1984). 
Mitochondrial toxins, including pesticides, 
are thought to play a role in the etiology of 
PD (Przedborski and Ischiropoulos 2005). 
Initially, attention focused on the herbicide 
paraquat because of its structural similarity to 
MPP+. In rodent models, paraquat induces 
a number of parkinsonism-like phenotypes, 
including motor degeneration with progres-
sive reduction in dopamine, and α-synuclein–
immunopositive neuronal pathology, especially 
when administered together with the fungi-
cide maneb (Norris et al. 2007; Thiruchelvam 
et al. 2000, 2003). Epidemiologic studies have 
now implicated a number of different pesti-
cides, including insecticides, fungicides, and 
herbicides, in the etiology of PD (Elbaz and 
Tranchant 2007).
In an observational study, the finding that 
an environmental agent’s impact is modi-
fied by a subject’s genetic variability may be 
considered to provide more compelling evi-
dence of a disease association. However, gene– 
environment interaction analyses for pesticides 
and PD have been rare, and replications are 
almost nonexistent (Deng et al. 2004; Elbaz 
et al. 2004; Hancock 2008; Kelada et al. 
2006). By design, our case–control study 
of incident PD in rural counties in central 
California provides a unique opportunity to 
investigate both self-reported occupational 
pesticide exposure and computer-modeled 
residential pesticide exposure, the latter using 
data collected during 30 years of state-man-
dated pesticide reporting and integrated 
into a geographic information system (GIS) 
approach. We based our occupational expo-
sure measure on “any kind” of occupational 
pesticide exposure, identical to the approach 
taken by Kelada et al. (2006), to replicate the 
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Ba c k g r o u n d: Research suggests that independent and joint effects of genetic variability in the 
  dopamine transporter (DAT) locus and pesticides may influence Parkinson’s disease (PD) risk.
Ma t e r i a l s and Methods: In 324 incident PD patients and 334 population controls from our rural 
California case–control study, we genotyped rs2652510, rs2550956 (for the DAT 5´ clades), and 
the 3´ variable number of tandem repeats (VNTR). Using geographic information system meth-
ods, we determined residential exposure to agricultural maneb and paraquat applications. We also 
collected occupational pesticide use data. Employing logistic regression, we calculated odds ratios 
(ORs) for clade diplotypes, VNTR genotype, and number of susceptibility (A clade and 9-repeat) 
alleles and assessed susceptibility allele–pesticide interactions.
re s u l t s: PD risk was increased separately in DAT A clade diplotype carriers [AA vs. BB: OR = 1.66; 
95% confidence interval (CI), 1.08–2.57] and 3´ VNTR 9/9 carriers (9/9 vs. 10/10: OR = 1.8; 95% 
CI, 0.96–3.57), and our data suggest a gene dosing effect. Importantly, high exposure to paraquat 
and maneb in carriers of one susceptibility allele increased PD risk 3-fold (OR = 2.99; 95% CI, 
0.88–10.2), and in carriers of two or more alleles more than 4-fold (OR = 4.53; 95% CI, 1.70–12.1). 
We obtained similar results for occupational pesticide measures.
discussion: Using two independent pesticide measures, we a) replicated previously reported gene–
environment interactions between DAT genetic variants and occupational pesticide exposure in men 
and b) overcame previous limitations of nonspecific pesticide measures and potential recall bias by 
employing state records and computer models to estimate residential pesticide exposure.
co n c l u s i o n: Our results suggest that DAT genetic variability and pesticide exposure interact to 
increase PD risk.
key w o r d s : dopamine transporter, gene–environmental interactions, occupational and envi-
ronmental exposures, Parkinson’s disease, pesticides. Environ Health Perspect 117:964–969 
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previous analysis as closely as possible. We did 
not attempt to extend the occupational expo-
sure analysis to selected agents because such 
data were too sparse for an interaction analysis 
and were more likely to be biased because of 
subject recall. For residential exposures derived 
from our GIS model, we concentrated on esti-
mating paraquat and maneb exposures because 
a) it has been hypothesized that paraquat is 
transported into dopamine cells by DAT 
(Shimizu et al. 2003), although this notion 
has been challenged (Richardson et al. 2005); 
b) animal data suggest that multiple paraquat 
applications or exposure to both maneb and 
paraquat are needed to cause PD-like pathol-
ogy in these models (Thiruchelvam et al. 
2000); and c) paraquat and maneb are both 
commonly used by the agricultural businesses 
in the studied counties, and only four subjects 
considered residentially exposed to maneb 
were unexposed to paraquat, so analysis of 
maneb alone would be inconclusive.
We have tested the gene–environment 
hypothesis that DAT genetic variants alone 
and in combination with occupational or 
residential pesticide exposures increase sus-
ceptibility to PD. We aimed to replicate the 
findings of Kelada et al. (2006) using our 
occupational pesticide measures. In addition, 
with our GIS model we hoped to overcome 
previous limitations of a) nonspecific pesticide 
exposure assessment and b) potential biases 
introduced by subject recall of self-  reported 
pesticide exposures.
Materials and Methods
All procedures described have been approved 
by the University of California at Los Angeles 
(UCLA) Human Subjects Committee, and 
we obtained informed consent from all 
  participants.
Subject recruitment. Using a population-
based approach, we recruited cases and control 
subjects in three central California counties: 
Fresno, Tulare, and Kern. Case definition 
and recruitment criteria have been described 
in detail elsewhere (Kang et al. 2005). Briefly, 
with the help of neurologists practicing in or 
near this region, large medical groups, and 
public service announcements, we contacted 
patients with incident PD residing in these 
counties. For the analyses presented here, 
we enrolled cases from early 2001 until July 
2007; cases were examined by UCLA move-
ment disorder specialists at least once, and 
confirmed as having clinically “probable” or 
“possible” PD (Kang et al. 2005).
We had initial contact with 1,124 poten-
tial cases and determined 600 to be ineligible: 
51 had never received a PD diagnosis, 133 did 
not live in the tricounty area or had not lived 
in California for 5 years or more, 394 had 
been diagnosed with PD more than 3 years 
before recruitment, and 22 patients were 
too ill to participate in our study. Another 
88 potential cases could not be examined or 
interviewed (46 withdrew, and 42 were too 
ill, had died, or had moved away before the 
scheduled appointment). A total of 436 eli-
gible cases were examined on multiple occa-
sions as necessary by our UCLA movement 
disorder specialists to confirm a diagnosis of 
clinically probable or possible PD using well-
established, stringent diagnostic criteria (Kang 
et al. 2005). Of the subjects examined, we 
excluded 95 because they received diagnoses 
such as parkinsonism from other causes, 12 
did not provide DNA samples or the samples 
they provided failed during genetic analyses, 
and five did not provide all necessary data. 
Ultimately, 324 cases contributed risk factor 
and genetic data to this analysis.
For the first year of recruitment, we 
identified control subjects > 65 years of age 
from Medicare lists, but Health Insurance 
Portability and Accountability Act (HIPAA) 
implementation prohibited the continued use 
of Medicare lists in subsequent years. Thus, we 
recruited most control subjects (> 75%) from 
randomly selected residential parcels identified 
from publicly available tax-collector records 
providing addresses for all zoned living units 
in Kern, Fresno, and Tulare Counties. For 
eligibility screening purposes, we had initial 
mail and/or phone contact with 878 potential 
control subjects. Control eligibility criteria 
included a) not having PD, b) ≥ 35 years of 
age, and c) currently residing in one of the 
three counties and having lived in California 
for at least 5 years before our screening. Only 
one person per parcel unit was allowed to 
enroll. We found 221 potential population 
control subjects were not eligible: 170 were 
too young, 45 were terminally ill or accord-
ing to respondents recently deceased, and six 
did not primarily reside in the tricounty area. 
Of the 657 eligible population controls, 285 
declined participation, were too ill, or had 
moved out of the area before interview; we 
enrolled 372 (57%), and for 334 we success-
fully genotyped for the DAT variants and had 
all necessary data for the analyses.
Pesticide exposures assessment. We con-
ducted telephone interviews to obtain demo-
graphic and risk factor information including 
detailed occupation and residential histories. 
We estimated pesticide exposures in the ambi-
ent residential environment resulting from 
applications to agricultural crops by employ-
ing a GIS computer model, which com-
bined geocoded lifetime residential histories, 
California pesticide use reporting data, and 
land use maps. A technical and more detailed 
discussion of our geocoding and GIS-based 
approaches is provided elsewhere (Costello 
et al. 2009; Goldberg et al. 2008). Here we 
briefly summarize the data sources and the 
exposure modeling process. Pesticide-use 
reports (PURs) are recorded by the California 
Department of Pesticides Regulations for all 
commercial applications of pesticides, includ-
ing agricultural applications. Each PUR 
record includes the name of the pesticide’s 
active ingredient, the poundage applied, the 
crop and acreage of the field, the application 
method, the date of application, and a PUR 
locator, which can be linked to the Public 
Land Survey System, a nationwide grid that 
parcels land into sections of approximately 
1 square mile (640 acres). To more precisely 
locate the pesticide application, we combined 
information from land use maps with that 
from PUR, as described in detail elsewhere 
(Rull and Ritz 2003). For each pesticide listed 
in the PURs, we created a year-specific aver-
age exposure estimate for each subject. First, 
we summed pounds of pesticide per year per 
acre applied within a 500-m radius buffer 
of each residence (Chester and Ward 1984; 
MacCollom et al. 1986; McElroy et al. 2003). 
Then, for each subject, we calculated a study 
period average by summing the year-specific 
averages for each chemical from 1974 to 1999 
and dividing that sum by 26, the total num-
ber of years in the relevant time period.
For residential pesticide exposure, we cate-
gorized subjects as “highly exposed” if they had 
a study period average that fell above the pes-
ticide-specific median value. Subjects exposed 
to both maneb and paraquat above the median 
value we considered highly exposed for this 
analysis; all other subjects we considered “low” 
or “unexposed.” We were unable to derive resi-
dential pesticide exposure estimates for 19 sub-
jects (9 PD and 10 control subjects) because 
they had not lived in one of the three counties 
during the period for which PUR pesticide data 
were available (1974–1999). We assumed that 
these individuals had not been exposed and 
performed sensitivity analyses excluding these 
individuals. The average amount of maneb and 
paraquat applied near homes of study subjects 
was relatively stable throughout the time win-
dow of 1974–1999, except that annual para-
quat exposure increased in the late 1990s.
Additionally, we created estimates of occu-
pational exposure to pesticides for subjects who 
had held jobs in the agricultural sector, assign-
ing them into categories of “likely exposed” 
when they reported pesticide handling and 
applications or fieldwork, and “possibly 
exposed” when reporting managerial, produce 
processing, and other nonfield farmwork; 
all others we considered “not occupationally 
exposed”(Young et al. 2004). Only 15 (9%) 
of the 167 subjects considered occupation-
ally exposed were also considered residentially 
highly exposed to both maneb and paraquat.
Selection of single nucleotide poly-
morphisms and laboratory methods for 
genotyping. From 22 single nucleotide poly-
morphisms (SNPs) found in the 5´ region Ritz et al.
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of DAT, Kelada et al. (2005) identified eight 
haplotypes that can be grouped into two evo-
lutionary clades, A and B (Kelada et al. 2006). 
Although these authors used six SNPs to 
identify the haplotypes for categorization into 
A and B clades, four of these provide redun-
dant information because they are in linkage 
disequilibrium. Only two SNPs, rs2652510 
(–2315) and rs2550956 (–2296), are needed 
to define the 5´ clades, and were genotyped 
along with the 3´ variable number of tandem 
repeats (VNTR). We considered the 5´ A 
clade and the 3´ VNTR 9-repeat susceptibil-
ity alleles; thus, an individual could have a 
maximum of four susceptibility alleles: two 
copies of the A clade 5´ region and two copies 
of the 9-repeat 3´ VNTR.
Participants provided blood or buccal 
samples for genetic analyses. Blood/buccal 
samples were stored and processed at the 
UCLA Biologic Specimen Core Facility. 
All genotyping was done at the Mayo 
Clinic in Jacksonville, Florida. DAT SNPs 
rs2652510 and rs2550956 were amplified 
from 20 ng of genomic DNA using Applied 
Biosystems, Inc. (ABI) Taqman polymerase 
chain reaction (PCR) Mastermix (assay IDs 
C_3284852_10 and C_3284851_10, respec-
tively) (ABI, Foster City, CA). PCR products 
were analyzed on an ABI 7900 instrument 
using SDS version 2.2.2 allelic discrimina-
tion software (ABI). The 40 bp 3´ VNTR 
of DAT was amplified using FAM-labeled 
primers (Vandenbergh et al. 1992). PCR 
products analyzed on an ABI 3730 automated 
sequencer and the number of repeats were 
determined using GeneMapper 4.0 (ABI).
Statistical methods. We confirmed Hardy–
Weinberg equilibrium in PD cases and control 
subjects separately for all polymorphisms. We 
estimated main effects of genotype and diplo-
type frequencies, relying on logistic regression 
analyses to calculate odds ratios (ORs) and 
95% confidence intervals (CIs) adjusted for 
potential confounders including sex, smok-
ing status (ever/never), age (continuous), 
race (white, black, Latino, Asian, and Native 
American), county (Kern, Tulare, and Fresno), 
occupational pesticide use (unexposed, pos-
sibly exposed, likely exposed), and residential 
pesticide exposure to paraquat and/or maneb 
(none, low, high). We also categorized indi-
viduals by the number of susceptibility alleles.
We assessed interactions between the num-
ber of DAT susceptibility alleles and exposures 
to both pesticide measures by employing strat-
ified analyses and by introducing interaction 
terms into logistic models. The former can be 
directly compared with Kelada et al. (2006); 
estimation of ORs and CIs from logistic 
regression models, with interaction terms, was 
not appreciably different (data not shown).
We also performed main effect analyses 
stratified by sex and by age at onset (≤ 60, 
> 60 years of age at diagnosis for patients, or 
by interview date for control subjects) and 
performed sensitivity analyses evaluating 
Caucasians only to account for the possibility 
of population stratification in our mixed eth-
nicity group. SAS version 9.1 (SAS Institute 
Inc., Cary, NC) was used to perform uncon-
ditional logistic regression analyses.
Results
Study participants were predominantly 
Caucasian and older than 60 years of age 
and did not report a family history of parkin-
sonism (Table 1). PD patients were slightly 
Table 1. Characteristics of the California Central Valley study population.
  Cases (n = 324)  Controls (n = 334) 
Characteristic   [no. (%)]   [no. (%)]  OR (95% CI)
Sex 
  Male  179 (55.3)  168 (50.3)  Reference
  Female       0.82 (0.60–1.11)
Age (years)a
  ≤ 60  69 (21.3)  97 (29.0)  Reference
  > 60  255 (78.7)  237 (71.0)  1.51 (1.06–2.16)
Race/ethnicity
  White  264 (81.5)  268 (80.2)  Reference
  Black      3 (0.93)  12 (3.6)  0.25 (0.07–0.91)
  Latino    38 (11.7)  28 (8.4)  1.38 (0.82–2.31)
  Asian     3 (0.93)  10 (3.0)  0.31 (0.08–1.12)
  Native American  16 (4.9)  16 (4.8)  1.02 (0.50–2.07)
County
  Fresno  162 (50.0)  124 (37.1)  Reference
  Kern    99 (30.6)  136 (40.7)  0.56 (0.39–0.79)
  Tulare    63 (19.4)  74 (22.2)  0.65 (0.43–0.98)
Education (years)
  0 to < 12  58 (17.9)  34 (10.2)  1.34 (0.79–2.27)
  12  89 (27.5)  70 (21.0)  Reference
   > 12  177 (54.6)  230 (68.9)  0.61 (0.42–0.88)
First-degree relative with PD
  No   277 (85.5)  299 (89.5)  Reference
  Yes  47 (14.5)  35 (10.5)  1.45 (0.91–2.31)
Cigarette smoking
  Never smoker   174 (53.7)  145 (43.4)  Reference
  Current smoker  19 (5.9)  33 (9.9)  0.48 (0.26–0.88)
  Former smoker  131 (40.4)  156 (46.7)  0.70 (0.51–0.96)
Smoking (pack-years)
  0   174 (53.7)  145 (43.4)  Reference
  > 0 to < 10     63 (19.4)  71 (21.3)  0.74 (0.49–1.11)
  ≥ 10 to < 40     60 (18.5)  81 (24.3)  0.62 (0.41–0.92)
  ≥ 40   27 (8.3)  37 (11.1)  0.61 (0.35–1.05)
Occupational pesticide exposureb 
  Not occupationally exposed  206 (63.6)  236 (70.7)  Reference
  Possibly exposed  25 (7.7)  24 (7.2)  1.19 (0.66–2.15)
  Likely exposed    93 (28.7)  74 (22.2)  1.44 (1.01–2.06)
Residential pesticide exposure 
to maneb and paraquat
  None/low  286 (88.3)  319 (95.5)  Reference
  High    38 (11.7)  15 (4.5)  2.80 (1.52–5.25)
aAge [median (SD)]: Case [70.1(10.4)]; Controls [68.5 (12.5)]. bJob–exposure matrix classification of pesticide exposure was 
based on occupational codes and self-reported agricultural and ground maintenance pesticide applications.
Table 2. Associations between PD and genotypes/diplotypes of the 5´ and 3´ regions of DAT in the present 
study and Kelada et al. (2006).
   California Central Valley study   Kelada et al. (2006)
Genotype/diplotype  Cases [no. (%)]   Controls [no. (%)]   OR (95% CI)a  OR (95% CI)b
5´ Clade diplotype
  BB  111 (34.3)  136 (40.7)  Reference  Reference
  BA  137 (42.3)  132 (39.5)  1.26 (0.89–1.80)  1.14 (0.81–1.61)
  AA  76 (23.5)  66 (19.8)  1.66 (1.08–2.57)  1.40 (0.90–2.20)
3´ VNTR genotype
 10/10  179 (55.3)  200 (59.9)  Reference  Reference
   9/10  113 (34.9)  109 (32.6)  1.15 (0.82–1.61)  1.31 (0.95–1.82)
   9/9  28 (8.6)  16 (4.8)  1.86 (0.96–3.57)  1.33 (0.74–2.39)
Rare genotypesc  4 (1.2)  9 (2.7)  NC  NC
NC, not calculated.
aOR adjusted for sex, smoking (ever/never), age, and race. bOR adjusted for sex, smoking (ever/never), and age. cRare 
genotypes include 3/3, 3/9, 3/10, 8/10, and 10/11.DAT, pesticides, and Parkinson’s
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older, more often male, and less educated than 
were control subjects. They were also more 
likely to have never smoked cigarettes or to 
have quit smoking and to have been pesticide 
exposed. High residential exposures to both 
paraquat and maneb between 1974 and 1999 
increased the risk of PD more than 2-fold 
(adjusted OR, 2.32; 95% CI, 1.23–4.40), 
and occupational exposure increased risk of 
PD by approximately 50% (males: adjusted 
OR, 1.56; 95% CI, 0.95–2.56).
Our data suggest a moderate increase in the 
risk of PD separately for both the homozygous 
AA diplotype of the 5´ clade (OR, 1.66; 95% 
CI, 1.08–2.57) and for the 9/9 3´ VNTR (OR, 
1.86; 95% CI, 0.96–3.57; Table 2). Assessing 
the cumulative effect of susceptibility alleles 
(defined as the 5´ A clade and the 3´ VNTR 
9-repeat), we found a 50% increase in risk 
for carriers of more than two DAT suscepti-
bility alleles (OR, 1.50; 95% CI, 1.00–2.25; 
Table 3). Furthermore, our data also suggested 
an allele dosage effect with increasing number 
of susceptibility alleles (2 vs. 0 susceptibility 
alleles: OR, 1.26; 95% CI, 0.82–1.95; 3 vs. 0 
alleles: OR, 2.18; 95% CI, 1.17–4.06; 4 vs. 
0 alleles: OR, 3.61; 95% CI, 0.93–14.1). All 
results were similar when we restricted our anal-
yses to Caucasians only or when we stratified by 
sex or age at PD onset (≤ 60 and > 60 years).
When stratifying by levels of residential 
exposure to both maneb and paraquat, we 
found that high exposure increased risk almost 
3-fold in subjects who carried one DAT sus-
ceptibility allele and as much as 4.5-fold in 
carriers of two or more susceptibility alleles 
(OR, 4.53; 95% CI, 1.70–12.09). Yet, in 
those subjects with little or no residential 
exposure to these pesticides, we observed no 
indication of increase in risk with susceptibil-
ity allele carrier status or increasing number 
of susceptibility alleles (Table 4). Restricting 
analyses to Caucasians only, stratifying by age 
at onset, or stratifying by sex did not change 
these results. As in the previous study by 
Kelada et al. (2006), we examined the influ-
ence of occupational pesticide exposure in 
males only (n = 347). After adjusting for high 
residential exposure as well as the other rel-
evant factors, we observed a 2-fold and almost 
3-fold increase in PD risk among likely pes-
ticide-exposed carriers of one and of two or 
more DAT susceptibility alleles, respectively, 
but no association among the occupationally 
unexposed regardless of the number of DAT 
susceptibility alleles (Table 5).
Discussion
Our population-based case–control study 
of PD conducted in a California population 
heavily exposed to pesticides replicates and 
extends evidence for an association between 
DAT variants and PD (Kelada et al. 2006)
and highlights possible interactions of 
disease-associated DAT susceptibility alleles 
and pesticide exposure (Tables 2–5).
All eight major DAT 5´ region haplotypes 
are part of two evolutionary clades (clades A 
and B) (Kelada et al. 2006). In vitro study 
of the six common haplotypes indicated that 
the two most prevalent haplotypes of clade A 
have 40–50% higher luciferase activity com-
pared with the two most prevalent haplo-
types of clade B (Kelada 2005). A caveat is 
that in vitro gene reporter assays are often 
dependent on cell type, transcription factor, 
and chromatin context. In contrast, direct 
in vivo human imaging of DAT binding and 
gene expression studies in postmortem brains 
suggest that B clade haplotypes are associated 
with higher DAT levels (Drgon et al. 2006). 
Conflicting functional results are difficult to 
reconcile, but, in agreement with Kelada et al. 
(2006), we subscribe to the view that in vivo 
measures are more likely to be representative 
of the true physiologic picture. Thus, our 
data suggest that lower DAT function/levels 
due to clade A may increase susceptibility 
to PD and, by extension, that DAT levels 
affect PD risk only in those   subjects who are 
  pesticide exposed.
Thus, the combination of these genetic 
associations and previous in vivo functional 
observations appears to contradict the long-
held belief that DAT provides a gateway for 
MPP+, paraquat, and maneb and thus poten-
tiates their neurotoxic effects in dopaminer-
gic neurons (Edwards 1993). To date, there 
remains no conclusive evidence that pesti-
cides enter dopaminergic neurons via DAT; 
in fact, a recent study showed DAT to be an 
unlikely transporter for paraquat (Richardson 
et al. 2005). Indeed, the selective vulnerabil-
ity underlying loss of dopaminergic neurons 
Table 4. Associations with PD by number of susceptibility allelesa in the 5´ and 3´ region of DAT and resi-
dential paraquat and maneb exposure in the California Central Valley study.
  Residential paraquat and maneb exposure
  Zero/low  High
  Cases   Controls  ORb  Cases  Controls  ORb 
No. of susceptibility alleles   (n = 286)   (n = 319)  (95% CI)  (n = 38)  (n = 15)  (95% CI)
0  65  80  Reference  4  5  0.88 (0.22–3.48)
1  99  117  0.98 (0.63–1.52)  10  4  2.99 (0.88–10.21)
≥ 2  122  122  1.30 (0.85–2.00)  24  6  4.53 (1.70–12.09)
p-Value for trend (across all categories)         0.0006
aDefined as 5´ A clade and 3´ VNTR 9-repeat alleles [includes genotypes with rare alleles; i.e., a genotype containing a 
9 allele (e.g., 3/9) was counted as carrying one risk allele and all others were counted as zero risk alleles]. bOR adjusted 
for age (continuous), race/ethnicity, education (< 12, 12, > 12 years), smoking (ever/never), and occupational pesticide 
exposures (job–exposure matrix).
Table 5. Associations with PD in males only by number of susceptibility alleles in the 5´ and 3´ region of 
DAT and occupational pesticide exposure in DAT in the present study and Kelada et al. (2006).
   Unexposed/possibly exposed  Likely exposed
No. of susceptibility alleles  Cases (n)  Controls (n)  OR (95% CI)  Cases (n)  Controls (n)  OR (95% CI)
California Central Valley study: males (n = 347)a
0  26  26  Reference  13  18  Reference
1  34  46  0.70 (0.34–1.45)  28  18  2.00 (0.71–5.67)
≥ 2   42  43  0.94 (0.46–1.92)  36  17  2.83 (1.01–7.92)
p-Value for trend (across all categories)            0.05
Kelada et al. (2006): males (n = 417)b
0  23  37  Reference  7  17  Reference
1  49  60  1.21 (0.62–2.36)  14  23  1.63 (0.52–5.15)
≥ 2   59  87  1.17 (0.62–2.23)  26  15  5.66 (1.73–18.5)
aOR adjusted for age (continuous), race/ethnicity, education (<12, 12, >12 years), smoking (ever/never), and high residential 
paraquat and maneb pesticide exposure. bOR adjusted for age (< 60, ≥ 60), education (quintiles), and smoking (ever/never).
Table 3. Associations with PD by number of susceptibility allelesa in the 5´ and 3´ regions of DAT the pres-
ent study and Kelada et al. (2006).
    California Central Valley study   Kelada et al. (2006)
No. of susceptibility alleles  Cases [no. (%)]   Controls [no. (%)]  OR (95% CI)b  OR (95% CI)c
0  69 (21.3)  85 (25.5)  Reference  Reference
1  109 (33.6)  121 (36.2)  1.03 (0.67–1.56)  1.16 (0.75–1.78)
> 2  146 (45.1)  128 (38.3)  1.50 (1.00–2.25)  1.58 (1.03–2.40) 
2  98 (30.3)  102 (30.5)  1.26 (0.82–1.95)  NC
≥ 3  48 (14.8)  26 (7.8)  2.36 (1.31–4.24)  NC
p-Value for trend (across all categories)      0.005
NC, not calculated.
aDefined as 5´ A clade and 3´ VNTR 9-repeat alleles [includes genotypes with rare alleles; i.e., a genotype containing a 
9 allele (e.g., 3/9) was counted as carrying one susceptibility allele and all others were counted as zero susceptibility 
alleles]. bOR adjusted for sex, smoking (ever/never), age (continuous), and race. cOR adjusted for sex and age.Ritz et al.
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remains enigmatic. Placing the observed and 
now confirmed gene–pesticide interaction 
association in biologic context likely requires 
further understanding of the roles of DAT, 
paraquat and maneb, and the toxic mecha-
nisms they exert on neurons. Paraquat’s 
toxic action is often attributed to reduction– 
oxidation cycling that generates reactive oxy-
gen species (Przedborski and Ischiropoulos 
2005). For maneb, the neurotoxic mechanism 
may be mediated by ubiquitin-proteasome 
system inhibition (Wang et al. 2006; Zhou 
et al. 2004).
Most important in our study, risk of 
PD seems to depend on whether subjects 
are exposed to pesticides. We observed little 
indication that DAT susceptibility allele(s) 
affect risk in those unexposed to agriculturally 
applied maneb and paraquat or occupationally 
(albeit self-reported) exposure to any type of 
pesticide. For occupationally exposed males, 
we estimated an almost 3-fold increase in risk 
for those carrying two or more susceptibility 
alleles and a 2-fold increase in risk for those 
with only one allele, compared with those 
not carrying DAT susceptibility alleles. Our 
results thus replicate a strong gene–pesticide 
interaction (> 5-fold risk increase; Table 5) 
previously reported for occupationally pes-
ticide-exposed males (Kelada et al. 2006). 
Moreover, we employed our GIS-derived, 
record-based residential pesticide exposure 
estimates for maneb and paraquat and found 
that highly exposed subjects with one DAT 
susceptibility allele have an estimated 3-fold 
increase, and subjects with two and more 
alleles a 4.5-fold increase, in risk of PD com-
pared with those with no DAT susceptibility 
alleles. There was little or no indication of a 
DAT susceptibility allele association in sub-
jects with no or low residential pesticide expo-
sure as estimated by our GIS model (Table 4).
A limitation of our study is the relatively 
small sample size for some strata of our gene–
environment interaction analysis. This may 
affect the informativeness of the data and the 
interpretability of results. In research of rare 
diseases, such as PD, sample size is always an 
issue for gene–environment interaction stud-
ies. However, collaborations and data pool-
ing efforts to increase sample size are usually 
limited by the need to arrive at comparable 
and valid measures of exposures, in addition to 
identifying a large enough exposed population 
in each study.
A primary strength of our study is the esti-
mation of residential pesticide exposure using a 
GIS-based computer model and not subjects’ 
self-reports; therefore, our residential estimates 
are unlikely to be biased by differential recall. 
Some nondifferential exposure misclassifica-
tion possibly attenuates effect estimates, and 
we encountered some missing or incomplete 
address information and geocoding problems 
in our GIS approach. Residential pesticide 
exposure will also depend on wind patterns at 
the time of application, open windows, and the 
likelihood of tracking dust and pesticide resi-
dues into homes. There is no obvious reason 
why subjects would have participated in our 
study based on a history of living near agri-
cultural plots, and most rural residents might 
not know what was applied on fields near their 
homes in the past decades. It is even less likely 
that subjects would be able to self-select them-
selves according to both genotype and pesticide 
exposure. A strength of our study is that, in 
contrast to most previous occupational and 
environmental epidemiologic studies of PD, 
all of our diagnoses were clinically confirmed 
by one or more examinations by UCLA move-
ment disorder specialists, so disease misclassifi-
cation is likely to be minimal.
Our residential pesticide estimates are 
unique in the field of epidemiologic expo-
sure assessment, and our rationale for their 
use in this study is strong. In this region of 
California, our two pesticides of particular 
interest, maneb and paraquat, are both applied 
on common crops such as potatoes, dry beans, 
and tomatoes, and both survive in the soil for 
> 30 days (Oregon State University 1996a, 
1996b; U.S. EPA. 2005). Pesticide drift can 
expose rural residents to pesticides without 
direct occupational contact. For example, 
measurable concentrations have been detected 
in the air, in plants, and in animals away from 
application sites (Chester and Ward 1984; 
Currier et al. 1982; MacCollom et al. 1986). 
Outdoor and indoor air concentrations for 
agriculturally applied pesticides correlate 
with each other and also correlate with dis-
tance to the application sites (Kawahara et al. 
2005). Our GIS-derived method of residen-
tial exposure estimation has been validated 
using values determined for organochlorines 
and measurements of serum biomarkers for 
dichlorodiphenyldichloroethylene, a metabo-
lite of dichlorodiphenyltrichloroethane (Ritz 
and Costello 2006).
Direct evidence of any particular pesticide 
compound contributing to PD in humans is 
lacking (Brown et al. 2006). This is partially 
due to a dearth of exposure assessment tools 
that accurately document past and long-term 
pesticide exposures in humans. The relatively 
small effect size any single environmen-
tal toxin may exhibit, and the necessity for 
large sample sizes that allow for an efficient 
investigation of gene–environment interac-
tions among vulnerable subgroups, may have 
further hindered progress in this area. The 
availability of historical pesticide application 
data for California allowed us to develop a 
GIS-based method of assessing exposures to 
pesticides for residents of the highly agricul-
tural California Central Valley. Our study 
is unique in that a record-based rather than 
recall-based assessment of historical residential 
pesticide exposures was possible.
Conclusion
No previous epidemiologic study has been 
able to objectively assess general or specific 
historical residential pesticide exposure in PD; 
all prior studies relied on subjects’ recall and 
reporting of pesticide use. We used GIS to 
combine data from the California PUR and 
land use maps to identify agricultural pesticide 
applications in proximity of residences of PD 
cases and controls. In addition, we assessed 
occupational pesticide exposures according 
to job descriptions and self-reported pesticide 
use. We enrolled more incident, movement 
disorder specialist–confirmed cases from a 
high pesticide exposure environment than 
any study so far. Our genetic findings rep-
licate a prior report and provide additional 
support for a gene–environment interaction 
between pesticide exposure and variants of the 
DAT gene.
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